Verrica Pharmaceuticals (VRCA) Revenue (2021 - 2026)
Verrica Pharmaceuticals (VRCA) posted quarterly Revenue of $5.0 million for Q1 2026, up 46.06% year-over-year from $3.4 million in Q1 2025, and down 1.36% quarter-over-quarter from $5.1 million in Q4 2025.
Verrica Pharmaceuticals (VRCA) Revenue (2021 - 2026) Analysis & Trends
Verrica Pharmaceuticals' Revenue history runs 6 years deep, the most recent figure standing at $5.0 million for Q1 2026.
- In Q1 2026, Revenue rose 46.06% year-over-year to $5.0 million; the TTM figure through Mar 2026 stood at $37.2 million (up 245.97% YoY), while the FY2025 annual figure was $35.6 million, up 370.22% from the prior year.
- Revenue for Q1 2026 stood at $5.0 million, down from $5.1 million in the prior quarter.
- The five-year high for Revenue was $14.3 million in Q3 2025, with the low at $37000.0 in Q1 2023.
- The 5-year median for Revenue is $2.9 million (2023), against an average of $3.9 million.
- The sharpest annual moves came in 2022 and 2024: Revenue tumbled 96.41% in 2022, then jumped 10240.54% in 2024.
- Verrica Pharmaceuticals' Revenue stood at $68000.0 in 2022, then surged by 2823.53% to $2.0 million in 2023, then tumbled by 82.7% to $344000.0 in 2024, then soared by 1380.23% to $5.1 million in 2025, then decreased by 1.36% to $5.0 million in 2026.
- Business Quant data shows VRCA's Revenue at $5.0 million in Q1 2026, $5.1 million in Q4 2025, and $14.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.29 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 425.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 674.14 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.06 Bn |
| 10 | Verrica Pharmaceuticals | 104.71 Mn | 93.51 Mn | - | 5.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.86 Mn |
| Mar 31, 2026 | 5.02 Mn |
| Dec 31, 2025 | 5.09 Mn |
| Sep 30, 2025 | 14.34 Mn |
| Jun 30, 2025 | 12.70 Mn |
| Mar 31, 2025 | 3.44 Mn |
| Dec 31, 2024 | 344,000.00 |
| Sep 30, 2024 | 1.78 Mn |
| Jun 30, 2024 | 5.18 Mn |
| Mar 31, 2024 | 3.83 Mn |
| Dec 31, 2023 | 1.99 Mn |
| Sep 30, 2023 | 2.92 Mn |
| Jun 30, 2023 | 182,000.00 |
| Mar 31, 2023 | 37,000.00 |
| Dec 31, 2022 | 68,000.00 |
| Sep 30, 2022 | 8.32 Mn |
| Jun 30, 2022 | 214,000.00 |
| Mar 31, 2022 | 431,000.00 |
| Mar 31, 2021 | 12.00 Mn |